Major Histocompatibility Complex
Online ISSN : 2187-4239
Print ISSN : 2186-9995
ISSN-L : 2186-9995
Search
Advanced search
OR
Browse
Search
Volume 9, Issue 1
Displaying 1-1 of 1 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Original paper
  • Downregulation of Major Histocompatibility Complex Class I Expression in Polymorphonuclear Leukocytes by Triggering CD 1 6 Antigen
    Motoko Nishimura, Yoshihide Ishikawa, Shigeki Mitsunaga
    2002 Volume 9 Issue 1 Pages 8-15
    Published: 2002
    Released on J-STAGE: March 30, 2017
    DOIhttps://doi.org/10.12667/mhc.9.8
    JOURNAL FREE ACCESS
    Show abstractHide abstract

    Polymorphonuclear leukocytes (PMNs) constitutively express major histocompatibility complex (MHC) class I molecules on their surface. In spite of the prominent roles of PMNs in host immune defense, the roles of MHC class I molecules in PMNs, such as presenting intracellularly processed antigens to CD8+ T cells, or preventing the cytotoxic effect of natural killer (NK) cells by their upregulated expression levels, have not been fully investigated thus far. PMNs express two low-affmity Fc T receptors, Fc 7 R 11 (CD32) and Fc T R III (CD16). The intracellular signaling pathway of PMNs is activated by triggering or cross-linking CD 16, resulted in the upregulation of MHC class I expression. We found that the expression levels of MHC class I molecules of PMNs could be downregulated by triggering CD 16, but not by triggering CD32.

    View full abstract
    Download PDF (3300K)
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top